Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001477932-25-008179
Filing Date
2025-11-13
Accepted
2025-11-13 16:06:51
Documents
18
Period of Report
2025-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A vnrx_8ka.htm   iXBRL 8-K/A 27230
2 AMENDMENT NO. 1 TO UNDERWRITING AGREEMENT vnrx_ex11.htm EX-1.1 2154
8 vnrx_ex11img1.jpg GRAPHIC 248843
9 vnrx_ex11img2.jpg GRAPHIC 171661
10 vnrx_ex11img3.jpg GRAPHIC 70637
  Complete submission text file 0001477932-25-008179.txt   826291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20251107.xsd EX-101.SCH 5022
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20251107_lab.xml EX-101.LAB 15187
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20251107_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20251107_pre.xml EX-101.PRE 9628
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20251107_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_8ka_htm.xml XML 4428
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36833 | Film No.: 251478409
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)